Liu Zhuo-ran

ORCID: 0009-0004-4762-7107
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • DNA Repair Mechanisms
  • COVID-19 Clinical Research Studies
  • S100 Proteins and Annexins
  • Cancer Research and Treatments
  • Microtubule and mitosis dynamics
  • Chromosomal and Genetic Variations
  • Medical Research and Treatments
  • Antimicrobial Resistance in Staphylococcus
  • Antibiotic Resistance in Bacteria
  • Inflammasome and immune disorders
  • Digestive system and related health
  • Diabetes and associated disorders
  • Bacterial Identification and Susceptibility Testing
  • Bone and Dental Protein Studies
  • SARS-CoV-2 and COVID-19 Research
  • Neuroinflammation and Neurodegeneration Mechanisms

University of South China
2007-2024

Treatment of Klebsiella pneumoniae causing pyogenic infections is challenging. The clinical and molecular characteristics are poorly understood, antibacterial treatment strategies limited. We analyzed the K. from patients with used time-kill assays to reveal bactericidal kinetics antimicrobial agents against hypervirulent (hvKp). A total 54 isolates were included, comprising 33 hvKp 21 classic (cKp) isolates, cKp identified using five genes (iroB, iucA, rmpA, rmpA2, peg-344) that have been...

10.1128/spectrum.00640-23 article EN cc-by Microbiology Spectrum 2023-06-21

The aim of the present study was to investigate expression, localization and role centromere-associated protein E (Cenp-E) in hepatoma cells. Cenp-E mRNA expression levels HepG-2 human hepatocellular carcinoma LO2 normal hepatic cell lines following treatment with nocodazole were detected by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). Furthermore, Cenp‑E two types visualized using indirect immunofluorescence. RT‑qPCR also performed detect cells before after RNA...

10.3892/ol.2015.3721 article EN Oncology Letters 2015-09-18

Coronavirus Disease 2019 (COVID-19) is generally susceptible to the population, highly infectious, rapidly transmitted, and fatal. There a lack of specific drugs against virus at present vaccination most effective strategy prevent infection. However, studies have found that some groups, particularly patients with diabetes, show varying degrees weak immune reactivity various COVID-19 vaccines, resulting in poor preventive efficacy novel coronavirus diabetes. Therefore, this study, type 2...

10.1089/vim.2023.0097 article EN Viral Immunology 2024-03-01
Coming Soon ...